Income StatementBalance SheetCash FlowSegments
Zimmer Biomet Holdings logo

Zimmer Biomet Holdings Cash Flow Statement

Operating, investing, and financing cash movements

Zimmer Biomet Holdings generated $1.7B in operating cash flow over the trailing twelve months. After $216.2M in capital expenditures, free cash flow was $1.5B. Free cash flow decreased 0.0% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$1.7BNet Cash From Investing (TTM)-$2.0BNet Cash From Financing (TTM)$982.4MCapital Expenditures (TTM)$216.2MDepreciation And Amortization Cf (TTM)$1.1BNet Change In Cash (TTM)$276.9M
Latest FilingQ1 2026
Report Date2026-05-01
Market Cap$16.0B
P/E Ratio21.05
ROE6.07%

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Payment for contingent consideration liability (financing)—$17.4M—$7.6M—$69.0M
Proceeds from lines of credit—$0.0$220.0M———
Payment for Contingent Consideration (Financing)—$17.4M—$7.6M—$69.0M
Proceeds from issuance of debt$736.3M$1.7B—$744.0M——
Dividends paid$48.0M$47.8M$47.5M$47.5M$47.5M$46.9M
Maturities Of Senior Debt$850.0M$863.0M——$600.0M—
Payments Of Debt Issuance Costs$5.1M$16.1M$1.2M$5.4M$0.0—
Proceeds From Issuance Of Senior Long Term Debt$736.3M$1.7B—$744.0M——
Proceeds from exercises of stock options and other stock issuances$500.0K$16.7M$400.0K$20.9M$1.7M$12.3M
Other, net-$10.9M-$15.2M-$900.0K-$500.0K-$1.1M-$15.6M
Payment of Deferred Purchase Consideration—$17.4M—$7.6M—$69.0M
Noncontrolling interest transactions and other-$10.9M-$15.2M-$900.0K-$500.0K-$1.1M-$15.6M
Net cash from financing activities-$240.6M$575.4M$163.8M$483.8M—-$369.2M
Other financing activities—$17.4M—$7.6M—$69.0M
Payment of debt issuance costs$5.1M$16.1M$1.2M$5.4M$0.0—
Noncontrolling Interests Activity and Other-$10.9M-$15.2M-$900.0K-$500.0K-$1.1M-$15.6M
Proceeds from issuance of common stock$500.0K$16.7M$400.0K$20.9M$1.7M$12.3M
Repurchases of common stock$72.2M$229.8M$7.2M$0.0$250.0M$250.1M

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$160.0M———$166.9M—
Capital expenditures$51.5M$44.6M$50.1M$55.0M$74.8M$36.3M
Additions To Instruments$51.9M$59.7M$80.5M$86.0M$74.3M$77.2M
Payment for (Proceeds from) Other Investing Activity—$300.0K$0.0$3.5M$800.0K$6.2M
Payments to Acquire Intangible Assets$33.4M$2.4M$30.0M$10.0M$10.0M$39.0M
Hedge Investing Activities, Net-$2.8M-$1.0M-$2.5M$8.8M—$300.0K
Net cash from investing activities-$291.2M-$106.0M-$1.4B-$163.3M-$322.0M-$159.0M
Other investing activities—$300.0K$0.0$3.5M$800.0K$6.2M
Payments for Hedge Investing Activities-$2.8M-$1.0M-$2.5M$8.8M—$300.0K
Purchases of intangible assets$33.4M$2.4M$30.0M$10.0M$10.0M$39.0M
Payments for (proceeds from) hedge, investing activities-$2.8M-$1.0M-$2.5M$8.8M—$300.0K
Payments for Deposits$33.4M$2.4M$30.0M$10.0M$10.0M$39.0M

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Change in accounts payable-$117.3M-$36.4M$76.8M-$51.5M$112.9M-$183.0M
Change in income taxes payable/receivable—-$15.6M-$116.4M-$42.7M$0.0-$7.4M
Change in inventories-$87.9M$3.0M$37.2M$46.0M-$184.4M$20.9M
Other working capital changes-$85.5M$100.0K-$8.4M-$15.8M$35.1M-$23.5M
Change in receivables$49.6M$18.8M——$111.7M-$14.5M
Deferred income taxes-$11.9M-$21.8M-$21.8M-$21.8M-$21.8M—
Depreciation and amortization$263.6M$254.4M$271.8M$283.6M$284.0M$270.0M
Net cash from operating activities$506.3M$382.8M$378.2M$418.7M$517.4M$359.4M
Stock-based compensation$21.1M$19.6M$21.2M$25.3M$24.1M$24.2M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$454.8M$338.2M$328.1M$363.7M$442.6M$323.1M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$18.1M$7.0M$14.6M—$800.0K$1.1M
Contingent consideration (receivable) payable - financing activities—$17.4M—$7.6M—$69.0M
Net increase (decrease) in cash—$859.1M—$735.8M—-$167.7M
Payments Of Merger Related Costs Financing Activities—$0.0————